513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kodiak Gas Services reported third-quarter 2024 revenue of $324.6 million, up from $231.0 million a year earlier, and record quarterly Adjusted EBITDA of $168.4 million. The company posted a net loss of $6.2 million, compared with net income of $21.8 million in the prior-year quarter, after a $9.9 million impairment, a $10.4 million loss on asset sales and a $20.3 million non-cash hedge loss. It also raised the low end of its full-year 2024 Adjusted EBITDA guidance and gave an early 2025 Adjusted EBITDA outlook of $675 million to $725 million.
Total revenues were $324.6 million for the quarter ended September 30, 2024, versus $231.0 million in the year-earlier quarter.
Net loss was $6.2 million, versus net income of $21.8 million a year earlier, including a $20.3 million non-cash, mark-to-market loss on interest rate hedges.
Full-year 2024 Adjusted EBITDA guidance is now $600 million to $610 million, a $10 million increase to the low end.
Early 2025 Adjusted EBITDA outlook is $675 million to $725 million; the company repurchased one million shares for $25 million in the quarter.
Ormat Technologies reported third-quarter 2024 results for the period ended September 30, 2024. Total revenue rose 1.8% to $211.8 million, and Adjusted EBITDA rose 16.3% to $137.7 million, but net income attributable to stockholders fell 37.7% to $22.1 million and diluted EPS fell to $0.36 from $0.59. The company raised its full-year Adjusted EBITDA guidance to $540 million to $555 million and narrowed its full-year revenue guidance to $875 million to $893 million.
Q3 2024 total revenue was $211.8 million, up from $208.1 million a year earlier; net income attributable to stockholders was $22.1 million versus $35.5 million, which the company attributed mainly to a $9.4 million Kenya tax income recorded
Adjusted EBITDA was $137.7 million, up 16.3% from $118.3 million, with the Enel assets acquired in Q1 2024 among the contributors
2024 guidance: Adjusted EBITDA of $540 million to $555 million (raised); total revenues of $875 million to $893 million (narrowed)
Board declared a quarterly dividend of $0.12 per share, payable December 4, 2024, to holders of record as of November 20, 2024
Mueller Water Products reported fourth-quarter fiscal 2024 net sales of $348.2 million, up 15.5% from a year earlier, but GAAP net income fell to $10.0 million from $17.2 million after a $16.3 million goodwill impairment and an $8.7 million warranty charge. For the full fiscal year, net income rose to $115.9 million and diluted EPS to $0.74, and the company introduced fiscal 2025 net sales guidance of $1.34 billion to $1.36 billion and adjusted EBITDA guidance of $300 million to $305 million.
Q4 net sales $348.2 million vs. $301.4 million; Q4 diluted EPS $0.06 vs. $0.11, while adjusted diluted EPS rose 15.8% to $0.22
Fiscal 2024 net income $115.9 million vs. $85.5 million; diluted EPS $0.74 vs. $0.55; free cash flow $191.4 million vs. $61.4 million
Fiscal 2025 guidance: net sales $1,340 million to $1,360 million; adjusted EBITDA $300 million to $305 million
Year-end cash and cash equivalents $309.9 million against total debt of $449.5 million
Host reported third-quarter 2024 revenue of $1.319 billion, up 8.6% from a year earlier, while net income fell 25.7% to $84 million and Adjusted EBITDAre fell 10.2% to $324 million, partly due to lower insurance gains and 2023 business interruption proceeds. The company cut its full-year 2024 net income and Adjusted EBITDAre forecast midpoints by $25 million and $15 million, though it kept its comparable hotel RevPAR and Total RevPAR guidance unchanged. Shareholders face lower expected 2024 earnings, with hurricane damage continuing to affect Florida properties into 2025.
Third-quarter revenues were $1.319 billion, up 8.6% from $1.214 billion; diluted EPS was $0.12 versus $0.16.
Full-year 2024 net income guidance midpoint is $687 million, down from $712 million; Adjusted EBITDAre guidance midpoint is $1,630 million, down from $1,645 million.
Comparable hotel Total RevPAR rose 3.1% in the quarter; full-year RevPAR and Total RevPAR guidance was maintained.
The Don CeSar remains closed after Hurricanes Helene and Milton, with a phased reopening expected beginning in late first quarter 2025.
Xenia Hotels & Resorts reported a third-quarter net loss of $7.1 million, or $0.07 per share, narrowed from $8.5 million a year earlier, while total revenues rose to $236.8 million from $232.0 million. Adjusted EBITDAre fell 4.4% to $44.3 million, and the company lowered its full-year 2024 outlook for net income, Adjusted EBITDAre and Adjusted FFO per diluted share, citing renovation disruption, hurricanes and softer leisure demand.
Q3 2024 Adjusted EBITDAre was $44.3 million, down 4.4%; Adjusted FFO per diluted share was $0.25, down 3.8%
Full-year 2024 Adjusted EBITDAre guidance is $234 million to $242 million, a reduction of $9 million to $13 million from prior guidance
Full-year 2024 Adjusted FFO per diluted share guidance is $1.54 to $1.62, down $0.08 to $0.12 from prior guidance
Hurricanes are estimated to reduce Hotel EBITDA by approximately $2 million over the third and fourth quarters
MKS Instruments reported third quarter 2024 results, with revenue of $896 million, down from $932 million a year earlier but up from $887 million in the prior quarter. Profit measures improved year over year, with GAAP net income of $62 million and non-GAAP EPS of $1.72, versus $1.46 a year earlier. The company also gave fourth quarter 2024 guidance of $910 million in revenue, plus or minus $40 million, and non-GAAP EPS of $1.95, plus or minus $0.32.
Q3 2024 revenue was $896 million, versus $932 million in Q3 2023 and $887 million in Q2 2024.
GAAP net income was $62 million, or $0.92 per diluted share, versus $39 million, or $0.58, a year earlier.
Non-GAAP EPS was $1.72 and Adjusted EBITDA was $232 million, compared with $241 million in Q3 2023.
Q4 2024 outlook: revenue of $910 million (plus or minus $40 million) and non-GAAP EPS of $1.95 (plus or minus $0.32).
Arcus Biosciences reported third-quarter 2024 revenue of $48 million, up from $32 million a year earlier, but its net loss widened to $92 million from $71 million as research and development spending rose to $123 million. The company said its $1.1 billion in cash, cash equivalents and marketable securities should fund operations into mid-2027, and it expects year-end 2024 cash of $950 million to $985 million.
Q3 2024 revenue was $48 million versus $32 million in Q3 2023; nine-month revenue was $232 million versus $86 million.
Q3 2024 net loss was $92 million, or $1.00 per share, compared with $71 million, or $0.94 per share, a year earlier.
R&D expenses were $123 million in Q3 2024 versus $82 million, driven by late-stage clinical trial and headcount costs.
Cash, cash equivalents and marketable securities were $1.1 billion at September 30, 2024, up from $866 million at December 31, 2023.
Kyndryl reported fiscal second-quarter revenue of $3.8 billion, down 7% year over year, with a net loss of $43 million, or $(0.19) per diluted share, compared with a $142 million loss a year earlier. The company reaffirmed its fiscal 2025 outlook, including adjusted pretax income of at least $460 million, while revenue is expected to decline in the full year.
Revenue of $3.8 billion fell 7% year over year, reflecting reduced inherited no-margin and low-margin third-party content in contracts.
Net loss was $43 million, or $(0.19) per diluted share, versus $142 million, or $(0.62) per diluted share, a year earlier; adjusted pretax income rose 80% to $45 million.
Total signings were a record $5.6 billion, up 132% year over year; cash flow from operations was $149 million.
Fiscal 2025 outlook reaffirmed: adjusted pretax income of at least $460 million and constant-currency revenue growth of (2%) to (4%).
Crane NXT reported third-quarter 2024 sales of $403.5 million, up 14.3% from a year earlier, with the OpSec Security acquisition contributing $32.3 million of the increase. GAAP earnings per diluted share fell to $0.81 from $0.90, while Adjusted EPS rose to $1.16 from $1.09. The company narrowed full-year Adjusted EPS guidance to $4.22 to $4.30 from $4.10 to $4.35 and cut its Adjusted free cash flow conversion outlook to about 70% from about 100%.
Sales of $403.5 million, up 14.3%; core sales growth of 4.7%, and OpSec Security added $32.3 million (9.1%)
GAAP operating profit of $75.0 million versus $79.7 million a year earlier; GAAP operating margin 18.6% versus 22.6%
Full-year 2024 Adjusted EPS guidance narrowed to $4.22 to $4.30; Adjusted free cash flow conversion lowered to about 70% from about 100%
Quarterly dividend of $0.16 per share, payable December 11, 2024, to holders of record as of November 29, 2024
Fidelity National Financial reported third-quarter 2024 net earnings attributable to common shareholders of $266 million, or $0.97 per diluted share, down from $426 million, or $1.57 per share, a year earlier. Adjusted net earnings rose to $356 million, or $1.30 per share, from $333 million, and total revenue increased to $3.6 billion from $2.8 billion. The company attributes the GAAP decline to mark-to-market effects and non-recurring items, which it excludes from adjusted results.
Total revenue of $3,603 million for Q3 2024, compared with $2,778 million in Q3 2023
GAAP net earnings of $266 million ($0.97 per diluted share), compared with $426 million ($1.57) in Q3 2023
Adjusted net earnings of $356 million ($1.30 per share), compared with $333 million ($1.23) in Q3 2023
Title Segment adjusted pre-tax title margin of 15.9%, compared with 16.2% in Q3 2023
Innoviva reported third quarter 2024 total revenue of $89.5 million, up from $67.3 million a year earlier, driven by higher net product sales and royalties. Net income fell to $1.2 million, or $0.02 per share, from $82.0 million, or $1.26 per share, mainly because of unfavorable fair value changes in its equity and long-term investments.
Total revenue was $89.5 million for the quarter ended September 30, 2024, compared with $67.3 million for the same quarter of 2023.
Net product sales were $27.8 million, including U.S. net product sales of $19.7 million, a 68% increase from $11.8 million.
Net change in fair value of equity and long-term investments was unfavorable by $35.2 million, primarily due to a lower share price of Armata Pharmaceuticals.
Cash and cash equivalents totaled $260.6 million as of September 30, 2024.
Texas Pacific Land reported third-quarter 2024 results, with total revenue of $173.6 million, up from $172.3 million in the second quarter, while net income fell to $106.6 million from $114.6 million. The company also raised its quarterly cash dividend by 37% to $1.60 per share and posted an updated investor presentation.
Q3 2024 diluted EPS was $4.63, versus $4.98 in Q2 2024; nine-month net income was $335.6 million, up from $292.5 million a year earlier.
Total operating expenses rose to $46.2 million from $39.1 million, mainly due to higher legal and professional fees.
The board declared a quarterly cash dividend of $1.60 per share, up from $1.17, payable December 16, 2024.
Acquisitions in Q3 included northern Delaware Basin mineral interests for $120.3 million and Midland Basin surface acreage for $45.0 million.
Veeco reported third quarter 2024 revenue of $184.8 million, up from $177.4 million a year earlier, while GAAP net income fell to $22.0 million from $24.6 million. The company also updated its full-year 2024 outlook, narrowing its revenue range to $700 million to $720 million and its non-GAAP EPS range to $1.68 to $1.78, which matters to shareholders because profit declined even as sales grew.
Q3 2024 revenue was $184.8 million versus $177.4 million in Q3 2023.
GAAP diluted EPS was $0.36 versus $0.42; non-GAAP diluted EPS was $0.46 versus $0.53.
Q4 2024 guidance: revenue of $165 million to $185 million and non-GAAP diluted EPS of $0.35 to $0.45.
Updated FY 2024 outlook: revenue of $700 million to $720 million, down from $690 million to $730 million; non-GAAP EPS of $1.68 to $1.78, down from $1.65 to $1.85.
DoubleVerify reported third-quarter 2024 results on November 6, 2024, with revenue up 18% to $169.6 million and net income of $18.2 million, compared with $13.3 million a year earlier. The company adjusted its full-year revenue growth midpoint to 16%, citing moderated brand spending during the U.S. election season and a slower ramp in social measurement adoption, while raising its adjusted EBITDA margin midpoint to 33% and authorizing $200 million in additional share repurchases.
Net income of $18.2 million vs. $13.3 million a year earlier; diluted EPS of $0.10 vs. $0.08.
Adjusted EBITDA of $60.2 million, a 35% margin, vs. $45.7 million and 32% a year earlier.
Full-year 2024 revenue guidance of $660 million to $666 million, with growth midpoint adjusted to 16%; adjusted EBITDA guidance of $218 million to $224 million, with a 33% margin at the midpoint.
New $200 million repurchase authorization, bringing total available for buybacks to $275 million as of November 6, 2024.
Tanger reported third-quarter 2024 total revenues of $133.0 million, up from $117.3 million a year earlier, while net income available to common shareholders fell to $24.6 million from $27.2 million. The company raised its full-year 2024 guidance, including diluted Core FFO per share to $2.09 to $2.13 from $2.05 to $2.12.
Q3 2024 total revenues were $133.0 million versus $117.3 million in Q3 2023.
Q3 diluted EPS was $0.22 versus $0.26; FFO and Core FFO per diluted share were each $0.54 versus $0.50.
2024 diluted Core FFO per share guidance was revised to $2.09 to $2.13 from $2.05 to $2.12.
Diluted EPS guidance for 2024 was revised to $0.88 to $0.92 from $0.85 to $0.92.
Power Integrations reported third-quarter 2024 revenue of $115.8 million, up 9% from the prior quarter but down 8% from a year earlier, with GAAP diluted EPS of $0.25 versus $0.34 in the third quarter of 2023. For the fourth quarter, the company forecast revenue of $105 million plus or minus $5 million, below the third-quarter level, and also authorized a $50 million share repurchase and a 5% dividend increase.
Q3 2024 revenue $115.8 million: up 9% from Q2 2024 and down 8% from Q3 2023
Q4 2024 forecast: revenue $105 million plus or minus $5 million; GAAP gross margin 54% to 54.5%
Board authorized $50 million in share repurchases with no expiration date; quarterly dividend rises to $0.21 per share from $0.20, payable December 31, 2024
For the three months ended September 30, 2024, e.l.f. Beauty reported net sales up 40% to $301.1 million, but GAAP net income fell to $19.0 million from $33.3 million and GAAP diluted earnings per share fell to $0.33 from $0.58. The company raised its fiscal 2025 net sales and adjusted earnings outlook, which gives shareholders higher expected sales and adjusted profit, while quarterly GAAP profit declined.
Net sales rose 40% to $301.1 million from $215.5 million a year earlier.
GAAP net income was $19.0 million versus $33.3 million; adjusted diluted EPS was $0.77 versus $0.82.
Fiscal 2025 net sales outlook raised to $1,315-1,335 million from $1,280-1,300 million.
Fiscal 2025 adjusted diluted EPS outlook raised to $3.47-3.53 from $3.36-3.41.
LXP Industrial Trust reported third-quarter 2024 net income attributable to common shareholders of $4.7 million, or $0.02 per diluted share, down from $11.0 million, or $0.04, a year earlier, while Adjusted Company FFO fell to $46.7 million from $51.9 million. Gross revenues rose slightly to $85.6 million, and the board raised the quarterly common dividend 3.8% to $0.135 per share. The company also narrowed its 2024 Adjusted Company FFO guidance to $0.63 to $0.64 per diluted share.
Q3 2024 net income attributable to common shareholders was $4.7 million, or $0.02 per diluted share, versus $11.0 million, or $0.04, in Q3 2023.
Adjusted Company FFO was $46.7 million, or $0.16 per diluted share, versus $51.9 million, or $0.18, a year earlier.
Total gross revenues were $85.6 million, compared with $85.4 million in the prior-year quarter.
Declared a quarterly common dividend of $0.135 per share, up 3.8%, payable January 15, 2025.
Brink's reported third-quarter 2024 revenue of $1,259 million, up 3% on a GAAP basis, while GAAP operating profit fell 19% to $112 million and GAAP EPS fell 33% to $0.65. The company updated its full-year 2024 outlook, citing currency and market headwinds in global services, and said organic growth in ATM managed services and digital retail solutions is now expected to exceed 20%.
Q3 2024 revenue $1,259 million, up 3% GAAP; operating profit $112 million, down 19%
Q3 GAAP EPS $0.65, down 33%; non-GAAP EPS $1.51, down 27%
Security losses rose $10 million year over year, mainly from one large loss event; company does not expect this to affect the full-year outlook
Charles River reported third-quarter 2024 revenue of $1.01 billion, down 1.6% from a year earlier, with GAAP diluted EPS of $1.33, down 21.3%, and non-GAAP diluted EPS of $2.59, down 4.8%. The company raised its 2024 non-GAAP EPS guidance to $10.10-$10.30 from $9.90-$10.20 but cut its GAAP EPS guidance to $5.30-$5.50 from $5.65-$5.95, citing higher restructuring charges.
Q3 revenue $1.01 billion vs. $1.03 billion in Q3 2023; organic revenue declined 2.7%
GAAP diluted EPS $1.33 vs. $1.69; non-GAAP diluted EPS $2.59 vs. $2.72
2024 non-GAAP EPS guidance raised to $10.10-$10.30; GAAP EPS guidance cut to $5.30-$5.50
Board approved a $1.0 billion buyback on August 2, 2024; $899.3 million remained as of September 28, 2024
Astec Industries reported third quarter 2024 net sales of $291.4 million, down 3.9% from a year earlier, and a net loss of $6.2 million. The loss included an $8.4 million charge to settle a legacy litigation matter, while adjusted EPS rose to $0.31 from $(0.01). Shareholders face lower sales and a continued GAAP loss, partly offset by higher adjusted earnings.
Net sales were $291.4 million, down 3.9%, with Materials Solutions sales down 9.6% to $126.4 million
Net loss was $6.2 million, or $(0.27) per diluted share, including an $8.4 million legacy litigation settlement charge
Adjusted EPS was $0.31 compared with $(0.01) a year earlier; Adjusted EBITDA was $17.4 million, up $7.4 million
Free cash flow was $19.9 million in the quarter; for the nine months it was $(29.6) million
Macerich reported a third-quarter 2024 net loss attributable to the company of $108.2 million, or $0.50 per diluted share, compared with a loss of $262.5 million, or $1.22 per share, a year earlier. Total revenues rose to $220.2 million from $218.2 million, but FFO excluding certain items fell to $86.0 million, or $0.38 per share, from $100.6 million, or $0.45 per share. The company has not issued fiscal 2024 guidance since withdrawing it on April 30, 2024.
Q3 2024 net loss attributable to the company: $108.2 million, or $0.50 per diluted share, versus $262.5 million, or $1.22 per share, in Q3 2023
Q3 2024 total revenues: $220.2 million, versus $218.2 million a year earlier
FFO excluding certain items: $86.0 million, or $0.38 per share, versus $100.6 million, or $0.45 per share, a year earlier
Fiscal 2024 guidance remains withdrawn; the company is not providing an updated outlook
American Financial Group reported third quarter 2024 net earnings of $181 million ($2.16 per share), up from $177 million ($2.09 per share) a year earlier, while core net operating earnings fell to $194 million ($2.31 per share) from $208 million ($2.45 per share), mainly due to higher catastrophe losses including Hurricane Helene. The Board declared a $4.00 per share special dividend, totaling approximately $335 million, payable November 26, 2024, which shareholders of record on November 15, 2024 will receive.
Q3 2024 total revenues were $2.37 billion, up from $2.16 billion in Q3 2023.
Core net operating earnings were $194 million ($2.31 per share), down from $208 million ($2.45 per share) a year earlier.
Special dividend of $4.00 per share, approximately $335 million in aggregate, payable November 26, 2024 to holders of record on November 15, 2024.
The company estimates pretax losses of approximately $30 million from Hurricane Milton, to be reflected in fourth quarter 2024 results.
CVS Health reported third quarter 2024 results for the three months ended September 30, 2024. Total revenues rose 6.3% to $95.4 billion, but GAAP diluted EPS fell to $0.07 from $1.75 and Adjusted EPS fell to $1.09 from $2.21, mainly due to a decline in the Health Care Benefits segment, which recorded about $1.1 billion of premium deficiency reserves. The company expects these reserves to be substantially released in the fourth quarter of 2024.
Total revenues rose 6.3% to $95.4 billion; Health Care Benefits recorded an adjusted operating loss of $924 million versus adjusted operating income of $1.5 billion a year earlier.
GAAP diluted EPS was $0.07 versus $1.75 a year earlier; Adjusted EPS was $1.09 versus $2.21.
Restructuring charges of approximately $1.2 billion were recorded, including a $607 million store impairment tied to retail pharmacy stores to be closed in 2025.
Premium deficiency reserves of approximately $1.1 billion are expected to be substantially released during the fourth quarter of 2024.
Enovis reported third-quarter 2024 net sales of $505 million, up 21% on a reported basis, and a net loss from continuing operations of $34 million, or $0.61 per share, compared with a $0.36 loss a year earlier. Adjusted earnings per diluted share rose to $0.73 from $0.56, and the company raised its full-year adjusted EPS guidance to $2.75-$2.80, while narrowing its revenue and adjusted EBITDA expectations.
Q3 net sales of $505 million grew 21% reported and 6% on a comparable basis; Reconstructive sales rose 57% reported.
Q3 net loss from continuing operations was $34 million, or $0.61 per share; adjusted EPS was $0.73, up 30% year over year.
Full-year 2024 adjusted EPS guidance raised from $2.62-$2.77 to $2.75-$2.80.
Full-year revenue is estimated at $2.10 billion and adjusted EBITDA at $373-$378 million.
National Vision reported third quarter 2024 net revenue up 2.9% to $451.5 million, but a net loss from continuing operations of $8.4 million, compared with a loss of $0.4 million a year earlier. Adjusted Diluted EPS rose to $0.12 from $0.11, and the company reaffirmed its fiscal 2024 outlook for key operating metrics while lowering its capital expenditure outlook.
Net revenue rose 2.9% to $451.5 million; comparable store sales grew 1.4%.
Diluted EPS from continuing operations was $(0.11), versus $(0.00) in Q3 2023; Adjusted Diluted EPS was $0.12 versus $0.11.
Fiscal 2024 Adjusted Diluted EPS outlook of $0.45 to $0.50 was reaffirmed; capital expenditures outlook cut to $100 million to $105 million from $110 million to $115 million.
The company completed its comprehensive store fleet review and plans to open 30 to 35 new stores in fiscal 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.